BP settles with US for $4.5 billion in Gulf spill

BP said Thursday that it will pay $4.5 billion in a settlement with the U.S. government over the massive 2010 oil spill and will plead guilty to felony counts related to the deaths of 11 workers and lying to Congress.

The figure includes nearly $1.3 billion in criminal fines — the largest such penalty ever — along with payments to several government entities.

A person familiar with the settlement said two BP employees will also face manslaughter charges over the deaths of 11 people in the explosion of the Deepwater Horizon oil rig that triggered the massive spill. The person was not authorized to discuss the matter on the record and spoke on condition of anonymity.

"We believe this resolution is in the best interest of BP and its shareholders," said Carl-Henric Svanberg, BP's Chairman. "It removes two significant legal risks and allows us to vigorously defend the company against the remaining civil claims."

The settlement includes payments of nearly $2.4 billion to the National Fish and Wildlife Foundation, $350 million to the National Academy of Sciences and about $500 million to the Securities and Exchange Commission.

London-based BP PLC said in a statement that the settlement would not include civil claims under the Clean Water Act and other legislation, pending private civil claims and state claims for economic loss.

The charges BP will plead guilty to include 11 felony counts of misconduct or neglect of ships officers, one felony count of obstruction of Congress and one misdemeanor count each under the Migratory Bird Treaty Act and the Clean Water Act. The 11 counts related to the workers' deaths are under a provision of the Seaman's Manslaughter Act.

The obstruction charge is for lying to Congress about how much oil was pouring out of the ruptured well.

Attorney General Eric Holder was scheduled to discuss the settlement at an afternoon news conference in New Orleans.

BP made a profit of $5.5 billion in the third quarter.

The largest previous corporate criminal penalty assessed by the Department of Justice was a $1.2 billion fine imposed on drug maker Pfizer in 2009.

The Deepwater Horizon rig, 50 miles off the Louisiana coast, sank after the April 20, 2010, explosion. The well on the sea floor spewed an estimated 206 million gallons of crude oil, soiling sensitive tidal estuaries and beaches, killing wildlife and shutting vast areas of the Gulf to commercial fishing.

Nelda Winslette's grandson Adam Weise, of Yorktown, Texas., was killed in the blast. She says somebody needs to be held accountable, even if it doesn't end her family's pain.

"It just bothers me so bad when I see the commercials on TV and they brag about how the Gulf is back, but they never say anything about the 11 lives that were lost. They want us to forget about it, but they don't know what they've done to the families that lost someone," she said.

The spill exposed lax government oversight and led to a temporary ban on deepwater drilling while officials and the oil industry studied the risks, worked to make it safer and developed better disaster plans.

BP's environmentally-friendly image was tarnished, and independent gas station owners who fly the BP flag claimed they lost business from customers who were upset over the spill. BP chief executive Tony Hayward stepped down after the company's repeated gaffes, including his statement at the height of the crisis: "I'd like my life back."

The cost of BP's spill far surpassed the Exxon Valdez spill in 1989. Exxon ultimately settled with the U.S. government for $1 billion, which would be about $1.8 billion today.

The government and plaintiffs' attorneys also sued Transocean Ltd., the rig's owner, and cement contractor Halliburton, but a string of pretrial rulings by a federal judge undermined BP's legal strategy to pin blame on them.

At the time of the explosion, the Deepwater Horizon was drilling into BP's Macondo well. The rig sank two days later.

Read More..

Erdrich wins her first National Book Award

NEW YORK (AP) — The National Book Awards honored both longtime writers and new authors, from Louise Erdrich for "The Round House" to Katherine Boo for her debut work, "Beyond the Beautiful Forevers."

Erdrich, 58, has been a published and highly regarded author for nearly 30 years but had never won a National Book Award until being cited Wednesday for her story, the second of a planned trilogy, about an Ojibwe boy and his quest to avenge his mother's rape. A clearly delighted and surprised Erdrich, who's part Ojibwe, spoke in her tribal tongue and then switched to English as she dedicated her fiction award to "the grace and endurance of native people."

The works of two other winners also centered on young boys — Boo's for nonfiction, and William Alexander's fantasy "Goblin Secrets," for young people's literature. David Ferry won for poetry.

Boo's book, set in a Mumbai slum, is the story of a boy and his harsh and illuminating education in the consequences of crime or perceived crime. The author, a Pulitzer Prize-winning journalist currently on staff with The New Yorker, said she was grateful for the chance to live in a world she "didn't know" and for the chance to tell the stories of those otherwise ignored. She praised a fellow nominee and fellow Pulitzer-winning reporter, the late Anthony Shadid, for also believing in stories of those without fame or power.

Boo was chosen from one of the strongest lists of nonfiction books in memory, from the fourth volume of Robert Caro's Lyndon Johnson series to Shadid's memoir "House of Stone." Finalists in fiction, which in recent years favored lesser known writers, included such established names as Dave Eggers and Junot Diaz. Publishers have been concerned that the National Book Awards have become too insular and are considering changes, including expanding the pool of judges beyond writers.

Winners, chosen by panels of their peers, each will receive $10,000.Judges looked through nearly 1,300 books.

Ferry is a year older than one of the night's honorary recipients, Elmore Leonard. Ferry, 88, won for "Bewilderment: New Poems and Translations," a showcase for his versatile style. He fought back tears as he confided that he thought there was a chance for winning because he "was so much older" than the other nominees. Attempting to find poetry in victory, he called the award a "pre-posthumous" honor.

Alexander quoted fellow fantasy writer Ursula K. Le Guin in highlighting the importance of stories for shaping kids' imaginations and making the world a larger place than the one they live in.

"We have to remember that," Alexander said.

The ceremony was hosted by commentator-performer Faith Salie and went smoothly even though Superstorm Sandy badly damaged the offices of the award's organizer, the National Book Foundation, whose staffers had to work with limited telephone and mail access.

Honorary prizes were given to Leonard and New York Times publisher and chairman Arthur O. Sulzberger Jr.

Read More..

Beta Blockers May Calm Nerves, Keeping Them Banned by PGA and L.P.G.A.

Greg Norman, winner of 91 tournaments worldwide, remembers a time when panic attacks on the elite golf circuit were often alleviated with the illicit use of a common heart and blood pressure medicine, the beta blocker.

“In my day, lots of guys were on beta blockers,” Norman, 57, said in an interview at the P.G.A. Championship in August. “It wasn’t openly acknowledged, but it was obvious to the rest of us. A guy’s personality would change. In practice rounds or friendly matches, we’d see the real guy under stress. Then in competition, he was like a different, calmer person. Those guys were trying to take the nerves out of the game. But nerves are very much a part of the game.”

Norman was far from the only one with the tacit understanding that beta blockers, also prescribed for stage fright, were part of big-time golf. So in 2008, when the PGA and L.P.G.A. Tours were establishing their antidoping programs, beta blockers were included on the banned substance lists.

The little pill that inadvertently, or not so inadvertently, soothes the jitters and helps settle the bets in a recreational weekend match — nearly one in three Americans have high blood pressure, so it might be resolving a lot of $5 wagers — is strictly policed when the PGA Tour paydays top $1 million.

The permissibility of beta blockers in golf’s top level has come into focus anew this week. Charlie Beljan won a PGA Tour event Sunday, two days after being hospitalized with a panic attack. Beljan, who said that this week he was going to consult doctors near his home in Arizona, might be treated with medication to prevent future panic attacks. But in competition, he will not be allowed to take certain medications, like beta blockers, without applying for a therapeutic use exemption, which requires a review by an independent panel of doctors.

Dr. Nicole Danforth, a psychiatrist, the medical director of Massachusetts General Hospital’s sports psychology program and a former professional golfer, said, “I think beta blockers could treat the yips, and I think the tours think so, too, or they wouldn’t ban them.”

Beta blockers are prohibited in many sports other than golf, including Olympic sports. The PGA Tour took its lead from the United States Anti-Doping Agency and the World Anti-Doping Agency in adding beta blockers to its list.

“One of the many pharmacological uses of beta blockers is the steadying of hand tremors,” said Andy Levinson, the executive director of the PGA Tour’s antidoping program. “Anything requiring fine motor skills could be affected, something necessary in sports like archery or golf.”

At the 2008 Beijing Olympics, Kim Jong-su of North Korea had to return the silver medal he won in the 50-meter pistol event and the bronze he won in the 10-meter air pistol event after testing positive for propranolol, a beta blocker.

For millions of Americans who take beta blockers, enhancing athletic performance is far from the purpose. Beta blockers are heart medicines meant to control blood pressure, slow the heartbeat and treat a variety of other heart conditions. That they might help calm nerves in a pressure situation is almost an accidental side effect.

“It so happens that the response to an anxiety-producing situation is also driven by the sympathetic nervous system that the beta blocker is trying to control for the good of the patient’s heart,” said Dr. Binoy K. Singh, the associate chief of cardiology at Lenox Hill Hospital in New York.

But Singh said he knew of no long-term, randomized clinical trials measuring beta blockers’ effectiveness in resolving anxiety or improving performance in pressure situations, even if he has had patients tell him they have noticed a calmness in those settings.

There is, in fact, no universal agreement on whether beta blockers help or hurt in some athletic situations.

“Some level of anxiety is good for performance,” said Richard Ginsburg, a sports psychologist at the Harvard Medical School and Massachusetts General Hospital. “It keeps you on your game. A beta blocker can take away some edge, mellow you too much.”

Danforth, who twice played in the United States Women’s Open, agreed, though she added that beta blockers, purely from a golf perspective, had been likened to the stabilizing advantage some find using a long putter.

There are medical concerns for those who acquire beta blockers without a prescription, perhaps through the plethora of Web sites selling the drugs. Singh said there was a serious risk for people using beta blockers without a genuine, long-term medical need for them.

“They are a very powerful class of drugs that have enormous impact on essential bodily functions,” he said. “They are not without adverse effects.”

Beta blockers are far from the primary treatment for panic attacks. There are a variety of medications, doctors said, and there are multiple treatments that do not involve drugs. Among the most effective treatments has been cognitive behavioral therapy. Some anti-anxiety drugs, like Xanax or Valium, are not on most prohibited substance lists, including the one used by the PGA Tour.

But if a golfer on the PGA or L.P.G.A. Tours can prove a documented medical condition that requires the use of a prohibited substance, an exemption is granted. Levinson said a beta blocker exemption had been granted.

When it comes to the recreational golfing community, no doctors said they had a patient who requested a beta blocker prescription to help with the frustrations and strain of playing golf. Singh, who said he was a golfer who had played in stressful weekend matches, was asked if he had ever been tempted to take a beta blocker for the benefits it might bring to his scorecard.

“No, but I would have benefited from a better golf game,” he said.

Read More..

Double dip: Eurozone falls back into recession

The Eurozone is back in a recession, its first in three years, as gross domestic product for the debt-plagued 17-nation bloc contracted 0.1% in the third quarter from the earlier quarter.

In the second quarter, the currency collective tightened 0.2%, according to the official European Union statistics agency, Eurostat. Two consecutive quarterly slips make a recession.

Compared with a year earlier, GDP is down 0.6%. Eurostat said last month that unemployment in the bloc was at a record high of 11.6%. Protests and strikes rippled across Europe on Wednesday.

Growth in core countries such as Germany and France couldn't counteract the plunges in long-struggling, austerity-bound nations such as Spain and Italy. Portugal took an especially nasty 0.8% dive.

Even countries that had been expanding took a dive, with the Netherlands experiencing a 1.1% squeeze and Austria contracting 0.1%. Germany saw its growth slow to 0.2% in the third quarter from 0.3% in the second.

France, however, reversed a string of flat or down quarters with 0.2% expansion.

The wider, 27-member European Union escaped recession, its GDP advancing 0.1% in the third quarter after tightening 0.2% in the second. In Britain., fresh off the Summer Olympics, the economy boomed 1% after a 0.4% drop.

A separate Eurostat report Thursday showed annual inflation in the euro-currency area down to 2.5% in October, from 2.6% the previous month.

In a speech Thursday, European Central Bank President Mario Draghi urged governments to avoid tax hikes in favor of spending cuts as a strategy for fiscal consolidation. He also stressed the need for "calm pragmatism going forward.

"It is essential that all parties involved in Europe's large and complex path of reforms stick to their commitments," Draghi said.

ALSO:

Stocks edge up in early trading as data show Europe in recession

U.S. economy will fall behind China and even India, OECD predicts

Read More..

Pelosi decides to remain as House Democratic leader

Former House speaker Nancy Pelosi said Wednesday she will run to keep her job as the Democratic leader in the House.

WASHINGTON -- Nancy Pelosi, the liberal San Francisco congresswoman who became the first woman speaker of the House, will seek to remain the Democratic leader in the next Congress.

Pelosi made the announcement Wednesday to a packed meeting of her caucus.

"They say a picture is worth a million words. Well this picture is worth millions of aspirations of the American people," Pelosi told the gathering, according to a Democratic leadership aide in attendance at the closed meeting. "This new class makes our caucus historic. The first time in legislative history that a caucus will be a majority of women and minorities."

"The message is clear from the American people. They want us to work together to get things done. And that's what these folks are here to do. Just like all of you.

"We may not have the gavel, but as I can see in this room, we have the unity," Pelosi said, according to the leadership aide, who asked for anonymity to discuss the private meeting.

PHOTOS: Reactions to Obama's victory

Pelosi had been mum about her plans after Democrats failed to win the majority in Tuesday’s election.

A champion campaign fundraiser, Pelosi is regarded as a polarizing figure. Elected to the House in 1987, she was chosen by the Democratic rank and file in 2002 to succeed Richard A. Gephardt of Missouri as minority leader, becoming the first woman to head a party in either chamber of Congress, as well as the first top party leader in the House from California.

In 2007, she became speaker — and the first Californian to head the House — overseeing passage of the most far-reaching healthcare overhaul since the creation of Medicare, an economic stimulus program, and the revamping of financial regulations, often with little or no Republican support.  But while she — and her Democratic majority — ruled the House, she became a favorite Republican campaign target as evidence of what's wrong with Washington. In 2010, she ran again for minority leader after Democrats lost control of the chamber, but has stayed around in hopes of leading her party back to the majority.

Republicans welcomed the prospect of continuing to have Pelosi as a target.

"There is no better person to preside over the most liberal House Democratic Caucus in history than the woman who is solely responsible for relegating it to a prolonged minority status," said Paul Lindsay, a spokesman for the House GOP campaign arm. "This decision signals that House Democrats have absolutely no interest in regaining the trust and confidence of the American people who took the speaker’s gavel away from Nancy Pelosi in the first place."

PHOTOS: America goes to the polls

Follow Politics Now on Twitter and Facebook

richard.simon@latimes.com

Twitter: @richardsimon11

Read More..

Petraeus affair and the role of biographers

NEW YORK (AP) — The affair between retired Army Gen. David Petraeus and author Paula Broadwell is but an extreme example of the love/hate history between biographers and their subjects.

Even before their outing led to Petraeus' resignation as CIA director, Broadwell had been criticized for the rosy tone of "All In," which The Associated Press described in 2011 as "part hagiography and part defense" of his strategy in Iraq and Afghanistan. But as long as biographies are written by and about human beings, scientific precision will remain an ideal. The stories of famous women and men often are colored by rapture and disenchantment, confusion and bias.

"As with psychiatrists, same with biographers, you shouldn't sleep with your subject," Blake Bailey, the prize-winning biographer of authors John Cheever and Richard Yates, said with a laugh.

"The ideal case is to have no assumptions. ... But it is possible to write a great book and have strong opinions. ('Eminent Victorians' author) Lytton Strachey, the father of all modern biographers, had a very distinctive voice and a very distinctive perspective — a person looking down from the world at a great distance, quite disparagingly, but with vast humor that informs every word."

Broadwell conducted extensive interviews with both critics and supporters of Petraeus, but the finished story was overwhelmingly positive. She is far from alone in allowing personal or professional regard to shape a biography, especially when the subject cooperates. Flattering books come out all the time, whether a biography of Dick Cheney by Weekly Standard writer Stephen Hayes or Chris Matthews' "Jack Kennedy: Elusive Hero."

Years spent together, as Broadwell had with Petraeus in Afghanistan, can make the biographer's experience intensely personal, whether sexual or not. Walter Isaacson did not avoid the unpleasant side of Steve Jobs, but acknowledged he had bonded strongly with the dying Apple CEO. Doris Kearns Goodwin was an aide to Lyndon Johnson who sometimes took notes while the ex-president lay in her bed, a relationship that she called platonic and described in her book on him, "Lyndon Johnson and the American Dream."

Some relationships end in court. Jimmy McDonough spent years working on an authorized biography of Neil Young, only to have Young withdraw support and attempt to stop publication, leading to mutual lawsuits and delay in the release of "Shakey," which came out in 2002. Some biographers seem energized by perceived sins, like the late Albert Goldman and his takedowns of Elvis Presley and John Lennon. Others use scholarship to build up or pick apart a figure from the distant past. Jon Meacham's new biography of Thomas Jefferson praises him as a subtle and effective politician, while a competing book, Henry Wiencek's "Master of the Mountain," faults Jefferson as a calculating slave holder who tolerated brutality.

David McCullough has likened the biographer's choice to picking a roommate, one you must live with for years. McCullough himself abandoned a Picasso book out of distaste for the painter's private life and chose men he related to for his two Pulitzer Prize winning presidential biographies, Harry Truman and John Adams. Former JFK aide Arthur M. Schlesinger Jr. won a Pulitzer for "A Thousand Days," his book on the Kennedy administration. But his reverence for the late president led Gore Vidal to dismiss "A Thousand Days" as a "political novel."

Biography often is the art of reconciling opposites. Robert Caro, the prize-winning biographer of New York municipal builder Robert Moses and Lyndon Johnson, has taken on men who have both inspired and dismayed him. A former investigative journalist, Caro sees his job as collecting as much information as possible and only then forming opinions. There is no such thing as "objective truth," he says, but there are enough "objective facts" to bring you close.

For his Moses and Johnson books, Caro has relied upon countless documents and interviews. He has labeled his Johnson series, begun soon after the president's death and still going, as a narrative of darkness and light, of the basest cruelty and the noblest achievement. His Moses book, "The Power Broker," was another epic of greatness and destruction and even more complicated to write because he actually interviewed Moses.

"You were awed by seeing the scope of his vision as he talked about it to you and explained it to you. You see him standing in front of this map, with a yellow pencil and sharp point, just gesturing toward this tri-state area that he sees as one entity and has a vision for it," says Caro, whose book was harshly criticized by Moses, but won the Pulitzer in 1975 and is now standard reading.

"But I was simultaneously talking to the people he had displaced, hounded them out of their homes. You have to show both of these things, his genius and its effect on people."

Authors have followed paths they never imagined before starting a book or encountering the subject. Edmund Morris was a prize-winning biographer of Theodore Roosevelt, but the chance to write about a living president led him to take unusual license. Granted years of access to Ronald Reagan, Morris was left so mystified that he inserted a fictionalized version of himself into the book, "Dutch," as a way of making sense out of the president.

Jane Leavy, author of a well-regarded biography on Mickey Mantle, said she had a hard time starting the book because of her childhood worship for the New York Yankees star. She decided the best way to move ahead was to acknowledge up front her memories, and map out the life of the flawed and troubled man she came to know and to hear about.

"He was multidimensional and far more complicated than the hagiographic biographies I read in school or the dark stories about him being a womanizer and an offensive drunk," she says. "No one is one way or another. The fact he was horrible to his wife doesn't invalidate his skill. So the task became why he treated people the way he did. And that's the biographer's job."

Read More..

Drug Compounders Get Help on Capitol Hill

WASHINGTON — Despite two decades of dire health warnings and threats of federal intervention, the specialty drugmakers at the center of the nation’s deadly meningitis outbreak have repeatedly staved off tougher federal oversight with the help of powerful allies in Congress.

Over the years, industry friends like Tom DeLay, the former House Republican leader from Texas, have come to its defense. Even Senator Edward M. Kennedy, regarded as the strongest health care advocate in Congress in recent times, dropped efforts to impose new safeguards.

But the pharmacists known as compounders are now facing their biggest regulatory threat as they confront questions on Wednesday and Thursday at Congressional hearings on the deadly outbreak. The question is whether Congress will move to oversee the niche industry more aggressively.

“A lot of the blame for the meningitis situation lies at Congress’s door,” said Larry D. Sasich, a research pharmacist who has written about compounders’ safety record. For specially mixed drugs that fall into a gray area of federal law, he said, “the protections for your cat or dog are stronger than for your wife and children.”

By Washington standards, the industry’s financial clout is not terribly large. The main trade group, the International Academy of Compounding Pharmacists, has spent $1.1 million on lobbying in the past decade, while major players in the business have given at least $300,000 to candidates since 2008, according to data from the Center for Responsive Politics, a research group in Washington.

But by positioning itself as a more affordable, community-based alternative to huge drug manufacturers, compounders have attracted broad support from politicians. They have become popular among proponents of hormone therapy to slow aging and advocates for the autistic, who often distrust the traditional pharmaceutical industry, and rely on compounders’ tailor-made blends.

If history is a guide, it often takes a disaster to get real change in the law.

In 1938, Congress passed the Food, Drug and Cosmetic Act after a drug company mixed an antibiotic with a toxic solvent and more than 100 people were killed, many of them children. In 1962, it amended that act to effectively create the modern drug approval system after thalidomide, a German drug intended to treat morning sickness in pregnant women, caused severe birth defects in Europe, said Kevin Outterson, an associate professor of law at Boston University.

Experts say the magnitude of the current crisis, in which more than 400 people have been sickened with meningitis and 32 have died, may finally spur action. This week’s hearings are expected to include testimony from the head of the Food and Drug Administration and the head of the Massachusetts pharmacy that produced the tainted drug.

Much of the scrutiny has focused on lax oversight by state boards and the Food and Drug Administration. But public health and drug industry experts say Congress is partly to blame for failing to clearly define the F.D.A.’s authority to police the practice.

A familiar cycle has played out in Washington since the 1990s: Publicity over illnesses or deaths from compounding drugs prompts outrage. Expert witnesses warn of the dangers of an unregulated industry. Proposals to fix the system follow. Then nothing happens.

“The public is at risk, an alarming great risk,” one pharmacist warned in 2003 Senate testimony after one person died and five more fell ill from contaminated medicine in 2002 produced by a South Carolina pharmacy.

Compounding, the practice of mixing medicines for individual patients, has grown in recent decades, helping fill gaps during drug shortages and offering cheaper versions of commercial drugs. But it has also become prone to abuse, with some pharmacies becoming, in effect, mini-drug manufacturers.

While the F.D.A. has clear authority to regulate drug manufacturers, state authorities have the main jurisdiction over pharmacies. Determining which category a company falls into is difficult because compounders are not required to give the F.D.A. access to their books.

Ultimately, stronger regulation has been stymied by sharp opposition from the industry and its defenders in Congress, both Democrats and Republicans, many of whom have compounders in their districts.

In 2008, the F.D.A. challenged what it said were misleading claims by compounders that their hormone therapy for older women was safer and more natural than that of big drug makers; it was met with staunch opposition, including objections from Suzanne Somers, the celebrity anti-aging advocate. The agency eventually prevailed.

Hundreds of members of Congress have attended conferences or taken part in charitable events and letter-writing campaigns organized by the International Academy of Compounding Pharmacists. The trade group said recently that its Congressional supporters had surged in recent years and that compounding had “gone from being a little-known practice to having a strong and steady presence in Washington.”

Texas, home to many compounding pharmacies and their main trade lobbying group, has been an important base of support, producing industry allies like Mr. DeLay and Representative Joe L. Barton, a Texas Republican.

Read More..

Toyota Prius recall: Automaker will fix nearly 700,000 hybrids

Toyota Motor Corp. announced two safety recalls for its flagship Prius hybrid.

The automaker said the steering intermediate extension shafts in 670,000 Prius cars sold in the U.S. need to be inspected and in some cases replaced. And 350,000 of those hybrids also will have to have their electric water pumps replaced.

Toyota will recall another 2 million vehicles worldwide, including the Prius and the Corolla, to fix the same problems.  

The gas-sipping Prius has become an important vehicle for Toyota, giving the company a reputation for producing fuel-efficient, green vehicles and quietly becoming one of the best sellers in the automaker’s lineup.

Toyota is on track to sell more than 250,000 Prius hatchbacks and station wagons this year, which will make it one of the best selling passenger cars in the U.S.  So far this year, the Prius has been the best selling car in California. Toyota sells more hybrids in the U.S. than all other automakers combined.

In the U.S., the recall includes 2004 through 2009 model year Prius hybrids.

The steering shaft problem results from a manufacturing error in which certain parts in the system did not have the required hardness and can deform.

Toyota said that in some of the cars, the electric motor that drives the water pump that circulates coolant through the hybrid components can shut off. In some cases this can cause the hybrid system to stop while the vehicle is being driven.
 
There have been no crashes or injuries reported for these two conditions.

Owners of vehicles covered by these safety recalls will receive an owner notification letter via first-class mail starting in December.  Any authorized Toyota dealer will perform these recalls at no charge.

This is the second large recall by Toyota in barely a month.  

In October, the Japanese automaker recalled 2.5 million vehicles nationally to fix a faulty power window switch that has been linked to at least nine injuries and several hundred reports of smoke and fire. In one instance reported to federal regulators, a passenger in a Camry was burned while trying to use a loose article of clothing to extinguish a fire caused by the switch.

The big recalls come as Toyota's vehicle sales in the U.S. have been surging after being derailed last year. Sales were hurt by manufacturing disruptions and inventory shortages caused by the Japanese earthquake. Massive recalls in 2010 for sudden-acceleration problems and other safety defects also added to Toyota's sales woes.

ALSO:

Will Toyota dump Yaris?

Honda rushes Civic redesign

Electric cars don't pencil out

Follow me on Twitter (@LATimesJerry), Facebook and Google+.

Read More..

Mike D'Antoni plans to coach Lakers on Sunday

Mike D'Antoni won NBA coach of the year in his first full season as head coach of the Phoenix Suns. (Jeff Gross / Getty Images)

By T.J. Simers

November 13, 2012, 8:36 a.m.

Just finished interviewing new Lakers Coach Mike D’Antoni by telephone, and how’s that for a fine start in town — he's talking to Page 2.

It’s going to take a little while to transcribe tape and write a column, but here’s how we began Tuesday morning.

"Got bad news for you, Mike. You’re losing 73% to 11% to Phil Jackson in a poll of who people would like to see coaching the Lakers."

D’Antoni laughs. "I’ve got some really close friends who are Laker fans and they were disappointed I got the job."

Reminded that the fans in Staples Center have been chanting, "We want Phil," D’Antoni says, "They can’t chant, 'We want Mike,' because they got him."

D’Antoni is still recovering from reconstructive surgery on his right knee. He’s getting around now with one crutch or a cane.

He will fly to Los Angeles on Wednesday, meet his team Thursday and says he’s probably aiming to make his Lakers coaching debut Sunday.

"When I feel better I’ll start coaching, and I think miraculously I’ll start feeling better when Steve [Nash] is feeling better," he says. "I’ve already tried coaching without him and that didn’t work out too well, so I’m thinking I’ll be smart this time."

If the tape recorder batteries hold up, more to come soon.

ALSO:

Phil Jackson gets call from Lakers and it's not what he expected

Lakers players surprised but enthused by hiring of Mike D'Antoni

It's unanimous: Lakers' selection of Mike D'Antoni over Phil Jackson is wrong

Read More..

Day-Lewis heeded inner ear to find Lincoln's voice

LOS ANGELES (AP) — A towering figure such as Abraham Lincoln, who stood 6 feet 4 and was one of history's master orators, must have had a booming voice to match, right? Not in Daniel Day-Lewis' interpretation.

Day-Lewis, who plays the 16th president in Steven Spielberg's epic film biography "Lincoln," which goes into wide release this weekend, settled on a higher, softer voice, saying it's more true to descriptions of how the man actually spoke.

"There are numerous accounts, contemporary accounts, of his speaking voice. They tend to imply that it was fairly high, in a high register, which I believe allowed him to reach greater numbers of people when he was speaking publicly," Day-Lewis said in an interview. "Because the higher registers tend to reach farther than the lower tones, so that would have been useful to him."

"Lincoln" is just the fifth film in the last 15 years for Day-Lewis, a two-time Academy Award winner for best actor ("My Left Foot" and "There Will Be Blood"). Much of his pickiness stems from a need to understand characters intimately enough to feel that he's actually living out their experiences.

The soft, reedy voice of his Lincoln grew out of that preparation.

"I don't separate vocal work, and I don't dismember a character into its component parts and then kind of bolt it all together, and off you go," Day-Lewis said. "I tend to try and allow things to happen slowly, over a long period of time. As I feel I'm growing into a sense of that life, if I'm lucky, I begin to hear a voice.

"And I don't mean in a supernatural sense. I begin to hear the sound of a voice, and if I like the sound of that, I live with that for a while in my mind's ear, whatever one might call it, my inner ear, and then I set about trying to reproduce that."

Lincoln himself likely learned to use his voice to his advantage depending on the situation, Day-Lewis said.

"He was a supreme politician. I've no doubt in my mind that when you think of all the influences in his life, from his childhood in Kentucky and Indiana and a good part of his younger life in southern Illinois, that the sounds of all those regions would have come together in him somehow.

"And I feel that he probably learned how to play with his voice in public and use it in certain ways in certain places and in certain other ways in other places. Especially in the manner in which he expressed himself. I think, I've no doubt that he was conscious enough of his image."

Read More..